Atomo Diagnostics (ASX:AT1): Not just another Rapid Diagnostic (RDT) company
Atomo Diagnostics (ASX:AT1) may be written off by some investors just because it is a rapid test kit company. Yes,…
How could the ASX attract more new listings? Here are 3 possibilities
How could the ASX attract more new listings? That is a question many local investors are pondering, and no doubt…
Mankayan: Here’s why Blackstone Minerals is making a big bet with this Fillipino Gold-Copper project
Blackstone Minerals‘ (ASX:BSX) announcement it was purchasing Mankayan could be lost on most investors as another one of those pivots…
Nanosonics (ASX:NAN): A disinfection company turning itself around and has gained 50% so far in 2025
Nanosonics (ASX:NAN) was in the best space to be during the pandemic – disinfection technology. Its flagship Trophon machines are…
Here are 5 Warren Buffett stock moves that were made in the last quarter
4 times per annum we get to see some Warren Buffett stock moves, and we like to recap some of…
Medigrowth delivers on its 2023 capital raising
It’s been a great couple of years for the Melbourne-based medicinal cannabis company Medigrowth Australia Pty Ltd. Back in mid-2023,…
The saga continues: 4 WiseTech directors quit en masse due to disagreements with Richard White
4 WiseTech directors quit en masse this morning, and that was just the start of the bad news facing the…
Want to know how to read stock charts well? Here’s your ultimate 2025 guide to Technical Analysis
Many investors will know technical analysis has become an increasingly important part of stock analysis, but they may not know…
How can you find the best stocks for retirement? It starts with looking at these 4 sectors
In this article, we ask the question: how can you find the best stocks for retirement? Investing in stocks can be…
Investors are overreacting to the $2.7bn Domain takeover bid: Here is why
The $2.7bn Domain takeover bid stole the headlines today. Shares in Domain (predictably) surged from their $3.13 close the day…
4 NZX stocks that should consider joining the ASX
NZX stocks typically are not on the radar of ASX investors (or any investors outside the Land of the Long…
When Will the RBA Cut Rates Again? Expert Predictions and Market Analysis
When Will the RBA Cut Rates Again? That’s the question everyone is asking, and the answer seems to be at…
Peter Dutton wants to break up insurers and investors are fearful, but should they be?
Some investors are worried that Peter Dutton wants to break up insurers. Not just because he is in with a…
ASX Futures in 2025: Riding the Wave or Getting Wiped Out? A Practical Guide for New Traders
New traders will encounter both risks and opportunities when trading ASX futures contracts on the Australian Securities Exchange in 2025.…
Recce’s R327G passed its Phase 2 trial with a 93% primary efficiacy endpoint!
Recce Pharmaceuticals (ASX:RCE) has completed its Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections) for RECCE® 327…